Skip to Main content Skip to Navigation
Journal articles

Hétérogénéité moléculaire des mésothéliomes pleuraux malins

Abstract : Malignant pleural mesothelioma (MPM) is predominantly an occupational cancer, most often linked to asbestos exposure. Malignant pleural mesothelioma prognosis is poor with a short survival median, due to the aggressiveness of tumor cells and the weak efficiency of conventional anti-cancer therapies. Clinical, histological, and molecular data suggest tumor heterogeneity between patients as it was also shown for other cancer types. Consequently, there is an urgent need to develop new therapies that take into account this heterogeneity and the molecular characteristics of malignant pleural mesothelioma, in particular by identifying new anti-cancer drugs targeting the molecular specificities of each malignant pleural mesothelioma. Malignant pleural mesothelioma is characterized by numerous molecular alterations at the chromosomal, genetic and epigenetic levels. Molecular classification based on gene expression profile has firstly defined two tumor groups, C1 and C2, and more recently, four groups. By integrating genetic and transcriptomic analysis, a C2LN tumor subgroup of the C2 group has been identified and characterized. In addition to tumor heterogeneity between patients, intra-tumor heterogeneity is supported by several evidences. Most therapeutic strategies that take into account the tumor molecular characteristics have focused on targeted therapies based on mutated genes. A more appropriate strategy would be to consider better-defined tumor groups on the basis of several molecular alterations types as it has been proposed for the C2LN subgroup. A robust definition of homogeneous tumor groups sharing common molecular characteristics is necessary for the development of effective precision medicine for malignant pleural mesothelioma.
Complete list of metadatas

Cited literature [46 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02478606
Contributor : Didier Jean <>
Submitted on : Tuesday, February 18, 2020 - 2:59:43 PM
Last modification on : Tuesday, October 20, 2020 - 1:44:43 PM

File

BULCAN-S-17-00332 sou.pdf
Files produced by the author(s)

Identifiers

Citation

Robin Tranchant, François Montagne, Marie-Claude Jaurand, Didier Jean. Hétérogénéité moléculaire des mésothéliomes pleuraux malins. Bulletin du Cancer, John Libbey Eurotext, 2018, 105 (1), pp.35-45. ⟨10.1016/j.bulcan.2017.11.007⟩. ⟨inserm-02478606⟩

Share

Metrics

Record views

306

Files downloads

746